Clinical trial Recruiting at 1 site Observational Ages 18 and up

Blood-based markers linked to aerobic (VO₂max/VO₂peak) fitness

Official title: Molecular Indicators of Systematic Fitness

Run by VO Health, Inc. · NCT07393841 · Data updated 2026-11-12

This project will try a blood test to see if it can predict VO₂max/VO₂peak in adults who can safely complete maximal exercise testing.

More Aging trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorVO Health, Inc.
Industry-sponsored
Locations1 site (New Haven, Connecticut)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedJanuary 5, 2028
Study endsMay 10, 2028
Registry record updatedFebruary 6, 2026
Trial IDNCT07393841 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older who can give informed consent, are willing to provide fasting blood samples and complete maximal/symptom-limited VO₂max testing, and have no medical contraindications to maximal exercise testing.

Probably not a fit

People with unstable cardiovascular conditions, acute illness, inability or unwillingness to undergo venipuncture, or those who cannot safely perform maximal exercise testing are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort that pairs directly measured VO₂max/VO₂peak with fasting, resting blood samples collected on the same day. Investigators will use multi-analyte molecular measurements (for example proteomics and other blood biomarkers) to build predictors of cardiorespiratory fitness and to examine how those features vary by age, sex, and activity history. A subset of participants may provide repeat VO₂max and blood samples over time to test whether the biomarkers track changes after self-directed training. No interventions are assigned by investigators; the dataset is intended to support biomarker development and analytic reliability testing.

Why it matters

Potential benefit: If successful, this could enable a simple blood test to estimate aerobic fitness, making fitness measurement easier and more accessible for monitoring and personalized guidance.

How similar studies have gone: Prior research has found promising links between blood proteomics/metabolomics and fitness, but robust, generalizable multi-analyte predictors of VO₂max are still preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be ≥18 years old
* Be able to understand and provide informed consent (English; additional languages may be added via amendment with translated materials)
* Be willing to complete VO₂max testing, blood draw, and questionnaires.
* Be able to safely perform maximal/symptom-limited exercise testing as determined by: PAR-Q+ screening and investigator review (included as an attachment) and resting vitals screening (heart rate)

Exclusion Criteria:

* Conditions that, in the investigator's judgment, or a medical doctor, makes maximal exercise testing unsafe (e.g., unstable cardiovascular symptoms)
* Contraindications or unwillingness to undergo venipuncture
* Acute illness (fever, significant respiratory illness) at the time of testing
* Failure to comply with procedures.

Where it's running

  • VO Health, Inc.
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.